Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)
Others
Ratios

Volitionrx (VNRX) Gross Profit (2019 - 2025)

Historic Gross Profit for Volitionrx (VNRX) over the last 7 years, with Q3 2025 value amounting to -$331290.0.

  • Volitionrx's Gross Profit rose 4278.85% to -$331290.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$2.7 million, marking a year-over-year increase of 4288.6%. This contributed to the annual value of -$4.1 million for FY2024, which is 3192.12% up from last year.
  • As of Q3 2025, Volitionrx's Gross Profit stood at -$331290.0, which was up 4278.85% from -$636846.0 recorded in Q2 2025.
  • Volitionrx's 5-year Gross Profit high stood at -$331290.0 for Q3 2025, and its period low was -$1.8 million during Q4 2021.
  • In the last 5 years, Volitionrx's Gross Profit had a median value of -$1.4 million in 2023 and averaged -$1.1 million.
  • In the last 5 years, Volitionrx's Gross Profit crashed by 44324.74% in 2021 and then skyrocketed by 5871.18% in 2024.
  • Over the past 5 years, Volitionrx's Gross Profit (Quarter) stood at -$1.8 million in 2021, then increased by 13.56% to -$1.6 million in 2022, then dropped by 6.19% to -$1.7 million in 2023, then soared by 35.95% to -$1.1 million in 2024, then skyrocketed by 68.75% to -$331290.0 in 2025.
  • Its Gross Profit stands at -$331290.0 for Q3 2025, versus -$636846.0 for Q2 2025 and -$670914.0 for Q1 2025.